Company KPI Data Charting Tools Stock Screener Industry Financials Time Series Tables

Login Start for Free

My Subscriptions My Account My Orders Log Out

Research Tools

Company KPI Data
Charting Tools
Stock Screener
Industry Financials
Time Series Tables

Login Start for Free

Overview
Financial Statements
KPIs & Operating Metrics
Estimates
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

Balance Sheet

Accounts Payables Assets Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Loans - Loss Allowance Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Pension Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Accured Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Cash Change in Intangibles Change in Working Capital Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Income Sales of Property, Plant and Equipment

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Market Capitalization Price Price to Book Price to Earnings Price to Sales

Growth Metrics

Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin Growth (1y)FCF Margin Growth (3y)Net Margin Growth (1y)Net Margin Growth (3y)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Sales Growth (1y)Return on Sales Growth (3y)

Income Statement

Consolidated Net Income EBIT EBITDA EBT Income from Continuing Operations Income towards Parent Company Interest & Investment Income Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Operating Expenses Profit After Tax Research & Development Revenue Selling, General & Administrative Share-based Compensation (IS)Shares Outstanding Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)

Others

Accumulated Depreciation & Amortization Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Revenue - Other

Ratios

Asset Utilization Ratio Assets Average Debt Ratio Debt to Equity EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Invested Capital Net Margin Operating Margin Return on Assets Return on Equity Return on Sales

Innate Pharma (IPHA) EBIT (2021)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Historic EBIT for Innate Pharma (IPHA) over the last 1 years, with Q4 2021 value amounting to -$54.7 million.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount